Literature DB >> 10574840

Drug company threatens legal action over Canadian guidelines.

M Shuchman.   

Abstract

Mesh：

Year:  1999        PMID： 10574840      PMCID： PMC1117127          DOI： 10.1136/bmj.319.7222.1388a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Article about Canadian guidelines on proton pump inhibitors was misleading.

Authors:  S Frame
Journal:  BMJ       Date:  2000-04-22

2.  Scientific harassment by pharmaceutical companies: time to stop.

Authors:  D Hailey
Journal:  CMAJ       Date:  2000-01-25       Impact factor: 8.262

3.  Unbalanced reporting of benefits and harms in abstracts on rofecoxib.

Authors:  Anders W Jørgensen; Karsten Juhl Jørgensen; Peter C Gøtzsche
Journal:  Eur J Clin Pharmacol       Date:  2010-02-17       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.